Building Quality Assurance/Quality Control Capacity at the UNM HSC Clinical and Translational Science Center

在 UNM HSC 临床和转化科学中心建立质量保证/质量控制能力

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT The National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences’ (NCATS) goal is to get more treatments to more people more quickly. However, many of the University of New Mexico (UNM) Clinical and Translational Science Center’s (CTSC) activities, especially pilot grants and KL2 scholar projects, require NIH prior approvals that involve very specific submission procedures that, if not implemented precisely, can lead to delays in study initiation. To address this, the hiring of a full time Quality Assurance/Quality Control (QA/QC) Manager is proposed. The long-term goal is to provide continual, robust, and efficient continuous quality improvement in the operations of the UNM CTSC and all interactions with NCATS. The objective is to improve the quality and efficiency of all CTSC submissions to NCATS. The rationale is that coordination of CTSC activities with those of NCATS is critical for achieving NIH priorities and enhancing clinical and translational research (CTR) locally, regionally, and nationally. The objective will be achieved through two specific aims: 1) Improve the quality, consistency and efficiency of CTSA-required information submitted to NCATS and the eRA Human Subjects System through the creation of a new, single point-of-contact position; and 2) Increase the capacity of the UNM CTSC for continuous, data-based improvement through careful evaluation of outcome metrics related to NCATS submissions, leadership of targeted Lean projects, education of hub investigators and staff, and sharing of best practices. Under the first aim, a QA/QC Manager will be hired and oriented, conduct an assessment of factors affecting current submission, develop a comprehensive QA/QC system for prior approvals including adapting or developing templates, checklists, workflow diagrams, and standard operating procedures; and actively participate in the NCATS QA/QC Discussion forum and other Consortium groups. Under the second aim, the Manager will track and evaluate the success of NCATS submissions; conduct targeted Lean events to continuously improve the quality, consistency, and efficiency of submissions; develop educational initiatives for CTSC faculty and staff related to prior approvals; and share best practices with the CTSA Consortium. The approach is innovative because the responsibilities spread across four positions will now be executed by one manager, who will work in close collaboration with the CTSA Consortium to design, implement, and evaluate improved submissions using best practices. The proposed position is significant because it will reduce administrative burden for both NCATS and the CTSC, and speed translation of CTR into clinical and public health practice.
项目总结/摘要 美国国立卫生研究院(NIH)国家转化科学推进中心(NCATS)的目标是 就是让更多的人更快地得到更多的治疗。然而,新墨西哥州的许多大学(UNM) 临床和转化科学中心(CTSC)的活动,特别是试点赠款和KL 2学者项目, 要求NIH事先批准,涉及非常具体的提交程序,如果不精确执行, 可能导致研究启动延迟。为了解决这个问题,聘请全职质量保证/质量控制 (QA/QC)经理。长期目标是提供持续、健壮和高效的连续 提高联合国墨西哥城技术服务中心的业务质量以及与国家技术援助中心的所有互动。目标是 提高CTSC向NCATS提交的所有材料的质量和效率。理由是,协调 CTSC与NCATS的活动对于实现NIH的优先事项和加强临床和 翻译研究(CTR)本地,区域和国家。这一目标将通过两个方面来实现。 具体目标:1)提高向委员会提交的CTSA要求的信息的质量、一致性和效率, NCATS和eRA人类受试者系统,建立一个新的单一联络点; 2)通过认真的、有针对性的改进, 评估与NCATS提交相关的成果指标,领导有针对性的精益项目,教育 中心调查员和工作人员的培训,以及分享最佳做法。根据第一个目标,QA/QC经理将 聘用和定向,对影响当前提交的因素进行评估,制定全面的 用于事先批准的QA/QC系统,包括调整或开发模板、检查表、工作流程图, 和标准操作程序;并积极参与NCATS QA/QC讨论论坛和其他 财团团体。根据第二个目标,管理人将跟踪和评估NCATS的成功 提交;进行有针对性的精益活动,以持续提高质量,一致性和效率, 提交;为CTSC教职员工制定与事先批准相关的教育计划;并分享 CTSA联盟的最佳实践。这种方法是创新的,因为责任分散 现在,四个职位的工作将由一名经理执行,他将与CTSA密切合作 联合体使用最佳实践设计、实施和评估改进的提交。拟议 这一立场意义重大,因为它将减轻NCATS和CTSC的行政负担, 将CTR转化为临床和公共卫生实践。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD S LARSON其他文献

RICHARD S LARSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD S LARSON', 18)}}的其他基金

UNM HSC Clinical and Translational Science Center
新墨西哥大学 HSC 临床和转化科学中心
  • 批准号:
    10165853
  • 财政年份:
    2015
  • 资助金额:
    $ 11.71万
  • 项目类别:
University of New Mexico Clinical and Translational Science Center
新墨西哥大学临床和转化科学中心
  • 批准号:
    9257477
  • 财政年份:
    2015
  • 资助金额:
    $ 11.71万
  • 项目类别:
UNM HSC Clinical and Translational Science Center
新墨西哥州 HSC 临床和转化科学中心
  • 批准号:
    10206291
  • 财政年份:
    2015
  • 资助金额:
    $ 11.71万
  • 项目类别:
University of New Mexico Clinical and Translational Science Center
新墨西哥大学临床和转化科学中心
  • 批准号:
    9085848
  • 财政年份:
    2015
  • 资助金额:
    $ 11.71万
  • 项目类别:
UNIVERSITY OF NEW MEXICO CLINICAL AND TRANSLATIONAL SCIENCE CENTER
新墨西哥大学临床与转化科学中心
  • 批准号:
    8365130
  • 财政年份:
    2011
  • 资助金额:
    $ 11.71万
  • 项目类别:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
  • 批准号:
    8365131
  • 财政年份:
    2011
  • 资助金额:
    $ 11.71万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8365134
  • 财政年份:
    2011
  • 资助金额:
    $ 11.71万
  • 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
CTSA 儿科研究基础设施
  • 批准号:
    8365132
  • 财政年份:
    2011
  • 资助金额:
    $ 11.71万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8365133
  • 财政年份:
    2011
  • 资助金额:
    $ 11.71万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8174728
  • 财政年份:
    2010
  • 资助金额:
    $ 11.71万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 11.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了